Bonn, 13 October 2017. In light of the planned acquisition of Monsanto, Bayer has signed an agreement to sell selected Crop Science businesses to BASF for EUR 5.9 billion. The transaction is subject to regulatory approvals as well as the successful closing of Bayer’s acquisition of Monsanto.
The assets to be sold include Bayer’s global glufosinate‐ammonium business and the related LibertyLink™ technology for herbicide tolerance, essentially all of the company’s field crop seeds businesses, as well as respective research and development capabilities. The transaction includes the transfer of relevant intellectual property and facilities, as well as more than 1,800 employees primarily in the United States, Germany, Brazil, Canada, and Belgium.